How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code MSV: System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi). View classification details, related manufacturers, 510(k) clearances, and recall records.
46 clearance records and 1 recall records in the covered releases, across 19 source company names and 1 product codes. Dated history runs from Jun 24, 1997 to Feb 6, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 1 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| MSV · System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) | 46 | 1 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Aptiva APS IgA ReagentK243979 · MSV | Inova Diagnostics, Inc. | 510(k) | Feb 6, 2026FDA decision date |
| EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA ImmunoassayK181329 · MSV | Phadia AB | 510(k) | Jun 25, 2018FDA decision date |
| ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enha…K162788 · MSV | Immco Diagnostics, Inc. | 510(k) | Jun 19, 2017FDA decision date |
| QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Control…K152875 · MSV | Inova Diagnostics, Inc. | 510(k) | Dec 21, 2015FDA decision date |
| QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS.K141274 · MSV | Inova Diagnostics, Inc. | 510(k) | Feb 13, 2015FDA decision date |
| ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAYK112414 · MSV | Phadia US, Inc. | 510(k) | Jun 22, 2012FDA decision date |
| HEMOSIL ACUSTAR ANTI-B2 GLYCOPROTEIN-I; IGG, IGM, IGG CONTROLS, IGM CONTROLSK091556 · MSV | Instrumentation Laboratory CO | 510(k) | May 21, 2010FDA decision date |
| THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCRK092757 · MSV | Thera-Test Laboratories, Inc. | 510(k) | Oct 9, 2009FDA decision date |
| IGG ANTI-ATHEROX TEST KITK072032 · MSV | Corgenix, Inc. | 510(k) | Apr 4, 2008FDA decision date |
| AESKULSKA BETA2-GLYCO-AK062217 · MSV | Aesku, Inc. | 510(k) | Dec 13, 2006FDA decision date |
| Data reduction program written for a specific automated microtiter plate instrument (Bio-Tek ELx800) reader) for use with Diastat Anti-Beta2 Glyc…Z-0674-05 · MSV | Diasorin Inc. | Recall | Apr 6, 2005FDA classification date |
| VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796K040449 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| VARELISA B2 GLYCOPROTEIN I IGA ANTIBODIES, MODELS 18948 AND 18996K040450 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896K040451 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| VARELISA B2 GLYCOPROTEIN I ANTIBODIES SCREEN, MODELS 19048 AND 19096K040452 · MSV | Pharmacia Deutschland GmbH | 510(k) | May 11, 2004FDA decision date |
| IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGG ELISAK030701 · MSV | Immco Diagnostics, Inc. | 510(k) | Sep 9, 2003FDA decision date |
| IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGM ELISAK030702 · MSV | Immco Diagnostics, Inc. | 510(k) | Sep 9, 2003FDA decision date |
| REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001K031208 · MSV | Corgenix, Inc. | 510(k) | Jul 7, 2003FDA decision date |
| DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100MK031177 · MSV | Axis-Shield Diagnostics, Ltd. | 510(k) | Jun 19, 2003FDA decision date |
| AUTOSTAT II ANTI-B-2 GLYCOPROTEIN I IGA ELISAK030397 · MSV | Hycor Biomedical , Ltd. | 510(k) | Mar 21, 2003FDA decision date |
| AUTOSTAT II ANTI-B-2 GLYCOPROTEIN-I IGM ELISAK022944 · MSV | Hycor Biomedical, Inc. | 510(k) | Dec 18, 2002FDA decision date |
| AUTOSTAT II ANTI-B-2 GLYCOPROTEIN I IGG ELISAK022945 · MSV | Hycor Biomedical, Inc. | 510(k) | Dec 18, 2002FDA decision date |
| QAB2A IGM ELISA KIT HRPK021610 · MSV | Cheshire Diagnostics , Ltd. | 510(k) | Jul 12, 2002FDA decision date |
| QAB2A IGG ELISA KIT HRPK021611 · MSV | Cheshire Diagnostics , Ltd. | 510(k) | Jul 12, 2002FDA decision date |
| QAB2A IGG ELISA KITK020695 · MSV | Cheshire Diagnostics , Ltd. | 510(k) | Apr 19, 2002FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.